Clinical Trials Logo

Filter by:
NCT ID: NCT01399762 Recruiting - Acute Stroke Clinical Trials

International Multicenter Registry for Mechanical Recanalization Procedures in Acute Stroke

ENDOSTROKE
Start date: January 2011
Phase: N/A
Study type: Observational

The purpose of the Endostroke Registry is to gather information on predictors of good or poor clinical outcome following mechanical recanalization therapies for acute ischemic stroke.

NCT ID: NCT01397864 Recruiting - Clinical trials for Hereditary Angioedema

C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks

Start date: July 2011
Phase:
Study type: Observational

This is a non-interventional treatment Registry of Hereditary Angioedema (HAE) patients treated with C1 inhibitor, either plasma-derived (pdC1INH) or the recombinant human form (rhC1INH / Ruconest), to observe adverse events and insufficient efficacy, and to assess the immunological profile following single and repeated treatment with Ruconest.

NCT ID: NCT01397110 Recruiting - Clinical trials for Pulmonary Arterial Hypertension

Respiratory and Physical Therapy in Patients With Associated Pulmonary Arterial Hypertension (APAH) With Congenital Heart Defects

Start date: January 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the influence of physical training on exercise capacity, quality of life, functional class, oxygen consumption and right ventricular function in patients with severe associated pulmonary arterial hypertension (APAH) as part of a congenital heart defect with / without Eisenmenger's Syndrome

NCT ID: NCT01391897 Recruiting - PTSD Clinical Trials

Epigenetics of Posttraumatic Stress Disorder and Somatoform Disorders in the Course of Psychotherapy

TREPS
Start date: January 2011
Phase: N/A
Study type: Observational

This reported observational clinical study aims at identifying epigenetic markers in a sample of patients undergoing high dose inpatient psychotherapy suffering from a variety of psychiatric/psychosomatic diseases such as somatoform disorders, posttraumatic stress disorder (PTSD), depression, anxiety disorders and eating disorders. The exact epigenetic markers that will be traced are yet to define. The investigators believe that 1. Epigenetic patterns found in the group of psychiatric patients show differences from healthy controls 2. Different diagnosis show differences in epigenetic patterns as well 3. Epigenetic patterns correlate to the severity of the psychosocial disorder as measured in interviews or psychometric ratings 4. Epigenetic patterns can change under inpatient high dose psychotherapy 5. Changes correlate to clinical psychometric variables.

NCT ID: NCT01390675 Recruiting - Heart Failure Clinical Trials

Anesthesia for Catheter Aortic Valve ImplantATIOn Registry

AVIATOR
Start date: June 2011
Phase:
Study type: Observational

In modern cardiac surgery and cardiology Transcatheter Aortic Valve Implantation (TAVI) is an emerging procedure for high-risk patients that are assumed to be otherwise inoperable. The investigators want to evaluate the specific intraoperative anesthesiologic characteristics cardiac anesthesiologists have to face during these procedures.

NCT ID: NCT01388621 Recruiting - Ovarian Cancer Clinical Trials

Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer

PROVE
Start date: October 2011
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to estimate the therapeutic efficacy of the experimental targeted regimen including the EGFR antibody panitumumab (in combination with carboplatin and either pegylated liposomal doxorubicin or gemcitabine) in relation to the respective standard combination in patients with a KRAS wildtype with platinum-sensitive recurrent ovarian cancer. It is expected that the progression free survival rate at 12 months is improved by the targeted regimen.

NCT ID: NCT01388231 Recruiting - Social Phobia Clinical Trials

Transfer of Manualized Cognitive-Behavioral Therapy (CBT) for Social Phobia Into Clinical Practice

Start date: September 2010
Phase: Phase 2/Phase 3
Study type: Interventional

The study aims at examining the effects of additional training in manualized cognitive-behavioral therapy (CBT) on outcome in routine psychotherapy for social phobia. The investigators will investigate how CBT, specifically the treatment procedures and manuals proposed by Clark and Wells (1995), can be transferred from controlled trials into the less structured setting of routine clinical care, and whether the health care system benefits from such developments. Private practitioners (N=36) will be randomized to one of two treatment conditions (i.e., training in manualized CBT vs. treatment as usual without specific training). The investigators plan to enroll 160 patients (80 per condition) to be able to detect differences of d=.50 between conditions at 1-beta=.80, given the drop-out rate of 25% (N=116 completers; N=58 per condition). The study is genuinely designed to promote faster and more widespread dissemination of effective interventions. The following research questions can be examined: (1) Can manualized CBT be successfully implemented into routine outpatient care? (2) Will the new methods lead to an improvement of treatment courses aned outcomes? (3) Will treatment effects in routine psychotherapeutic treatments be comparable to those of the controlled, strictly manualized treatment of the main study?

NCT ID: NCT01387035 Recruiting - Clinical trials for Pulmonary Hypertension

Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases

Start date: January 2010
Phase:
Study type: Observational

The purposes of this study are (I), to evaluate various screening methods for their ability to predict and to confirm Pulmonary Hypertension (PH) in scleroderma patients, and (II) to evaluate the incidence of PH (i.e. the number of new cases per year) in scleroderma patients.

NCT ID: NCT01386788 Recruiting - Clinical trials for Smoke Inhalation Patients

European Survey: Risk of Cyanide Poisoning in Smoke Inhalation

RISK
Start date: April 2009
Phase: N/A
Study type: Observational

Cyanide poisoning is commonly viewed as a rare but dramatic event, occurring in industrial or laboratory settings as the result of accidental releases of hydrogen cyanide (HCN) gas (e.g. in the case of fire) or salts in the case of suicide attempts. In fact, cyanide poisoning is considerably more common than is generally appreciated. Multiple clinical and post-mortem studies have demonstrated that HCN contributes to the toxicity of fire smoke. Cyanide acts primarily through its strong affinity for the iron-containing heme moiety, binding to numerous critical enzyme systems in the body and rendering them inactive. Of late, increasing attention has been paid to the relationship of cyanide and nitric oxide. The interactions appear to be complex, with cyanide inducing nitric oxide production by binding to N-methyl-D-aspartate (NMDA) receptors, as well as binding to nitric oxide synthase. The latter may be overcome by the presence of nitric oxide synthase inhibitors. Probably, the majority of the cyanide poisoning cases are due to smoke inhalation in closed-space fires. So far, there are no clear data available on the prevalence of cyanide poisoning in smoke inhalation. This information would be of great interest for all emergency physicians since a proven or supposed cyanide poisoning does not only requires an intensive supportive care, including the administration of supplemental oxygen and artificial ventilation, blood pressure support, and anticonvulsants, but also a rapid administration of a cyanide antidote. Therefore, it is the goal of this survey to assess the prevalence of cyanide poisoning in smoke inhalation victims. Only the data of patients with a cyanide measurement before specific antidote treatment will be included

NCT ID: NCT01385670 Recruiting - Clinical trials for Heart Defects, Congenital

InterSEPT: In‐Tunnel SeptRx European PFO Trial

InterSEPT
Start date: June 2011
Phase: N/A
Study type: Interventional

The objective of this study is to determine the safety, performance, and effectiveness of the SeptRx IPO PFO Closure System in the treatment of Patent Foramen Ovale (PFO) in patients who are amenable to percutaneous closure of their PFO defects.